PACE-PANCREAS_Patient specific Contrast Enhancement timing for pancreatic evaluation in Computer Tomography
Recruiting
- Conditions
- C25Malignant neoplasm of pancreas
- Registration Number
- DRKS00030191
- Lead Sponsor
- MU Klinikum der Universität München
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Indication for performing CTA of the pancreas.
Age-adjusted normal serum creatinine or creatinine clearance > 30 ml / min / 1.73 m2 for safe contrast administration
Exclusion Criteria
Contraindication to the performance of computed tomography
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method